This report is built using data and information sourced from databases, Daewoong Pharmaceutical Co., Ltd.’s corporate website, SEC filings, investor presentations and featured press releases, both from Daewoong Pharmaceutical Co., Ltd. and industry-specific third party sources.
Scope

- Daewoong Pharmaceutical Co., Ltd. - Brief Daewoong Pharmaceutical Co., Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Daewoong Pharmaceutical Co., Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Daewoong Pharmaceutical Co., Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Daewoong Pharmaceutical Co., Ltd.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.